Login to Your Account

Syndax slashes price, lowers its sights to raise $52.8M in IPO

By Marie Powers
News Editor

Thursday, March 3, 2016

Syndax Pharmaceuticals Inc. managed to squeak through the IPO window but not before slashing its price to $12, below its proposed range of $14 to $16, to collect $52.8 million – well below its initial target raise of approximately $81 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription